70.18 F
New York
July 25, 2021


Emergent CEO says FDA is holding over 100 million J&J Covid vaccine doses for further testing after botched shots

CNBC – For more and to sign up click here Robert Kramer, CEO, Emergent BioSolutions Scott Mlyn | CNBC The FDA is holding more than 100 million Johnson & Johnson Covid-19 vaccine doses for further testing after the agency found multiple safety violations at the plant — run by Emergent......

The leaders of Emergent, whose factory spoiled vaccine doses, will testify before a U.S. House panel.

New York Times
In a statement on Wednesday, the company said that it had responded to the F.D.A.’s observations with a “comprehensive quality enhancement plan” and had “already started making improvements.” On a recent call with investors, Mr. Kramer announced a management shake-up and said that while the company had “implemented multiple layers......

Canada’s regulator holds Johnson & Johnson vaccine over Emergent link.

New York Times
New York Times – For more and to sign up click here Canada’s drug and vaccine regulator said on Friday that it was withholding the release of the country’s first shipment of the Johnson & Johnson vaccine to verify its safety and quality. Health Canada, the regulator, said on Tuesday......

Stocks making the biggest moves in the premarket: J&J, Emergent BioSolutions, Micron Technology & more

CNBC – For more and to sign up click here Take a look at some of the biggest movers in the premarket: Johnson & Johnson (JNJ) – J&J said a batch of its Covid-19 vaccine that came from a Baltimore factory did not meet quality standards and will not be......

Emergent BioSolutions says it can make 1 billion Covid vaccine doses annually

CNBC – For more and to sign up click here As the U.S. makes headway in its coronavirus vaccination campaign, Emergent BioSolutions CEO Bob Kramer appeared on CNBC Wednesday to explain his company’s role in manufacturing doses. The Gaithersburg, Maryland-based contractor last year landed a multi-year deal to be the......

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Click whichever is suitable. Accept Read More